The Microbiome and Tuberculosis: Early Evidence for Cross Talk

MBio
Sivaranjani NamasivayamMatthew F Wipperman

Abstract

Tuberculosis (TB) is an ancient infectious disease of humans that has been extensively studied both clinically and experimentally. Although susceptibility to Mycobacterium tuberculosis infection is clearly influenced by factors such as nutrition, immune status, and both mycobacterial and host genetics, the variable pathogenesis of TB in infected individuals remains poorly understood. During the past two decades, it has become clear that the microbiota-the trillion organisms that reside at mucosal surfaces within and on the body-can exert a major influence on disease outcome through its effects on host innate and adaptive immune function and metabolism. This new recognition of the potentially pleiotropic participation of the microbiome in immune responses has raised the possibility that the microbiota may influence M. tuberculosis infection and/or disease. Similarly, treatment of TB may alter the healthy steady-state composition and function of the microbiome, possibly affecting treatment outcome in addition to other host physiological parameters. Herein, we review emerging evidence for how the microbiota may influence the transition points in the life cycle of TB infection, including (i) resistance to initial infection, (ii) in...Continue Reading

References

Dec 1, 1993·The Journal of Experimental Medicine·J L FlynnB R Bloom
Sep 1, 1995·American Journal of Public Health·M E Northridge
Jan 27, 1994·The New England Journal of Medicine·C P KellyJ T LaMont
Oct 16, 1999·The New England Journal of Medicine·A van RieP D van Helden
Oct 16, 2002·Infection and Immunity·Alissa ChackerianSamuel M Behar
Mar 27, 2003·Alimentary Pharmacology & Therapeutics·L BeaugerieUNKNOWN Study Group
May 1, 1954·Proceedings of the Society for Experimental Biology and Medicine·M BOHNHOFFC P MILLER
Apr 16, 2005·American Journal of Respiratory and Critical Care Medicine·Suzanne VerverPaul D van Helden
Feb 28, 2007·Archives of Internal Medicine·Michael N BatesKirk R Smith
Apr 7, 2007·Chest·Anita L KozyrskyjAllan B Becker
May 20, 2008·Tuberculosis
May 20, 2008·Tuberculosis
May 20, 2008·Tuberculosis
May 20, 2008·Tuberculosis
Jul 24, 2008·JAMA : the Journal of the American Medical Association·Diane V HavlirPaul Nunn
Nov 11, 2009·The Journal of Experimental Medicine·Aurelie CobatAlexandre Alcaïs
Jan 19, 2010·Nature Medicine·Thomas B ClarkeJeffrey N Weiser
May 22, 2010·Lancet·Knut LönnrothMario C Raviglione
Jun 29, 2010·Nature Immunology·Lionel Le BourhisOlivier Lantz
Jul 9, 2010·PLoS Biology·Marielle C GoldDavid M Lewinsohn
Mar 16, 2011·Proceedings of the National Academy of Sciences of the United States of America·Takeshi IchinoheAkiko Iwasaki
Apr 15, 2011·The New England Journal of Medicine·C Robert Horsburgh, Eric J Rubin
Sep 3, 2011·Science·Gary D WuJames D Lewis
Oct 12, 2012·Nature·Lars Kjer-NielsenJames McCluskey
Nov 28, 2012·BMC Microbiology·Zelin CuiXiaokui Guo
Feb 1, 2013·PloS One·Man Kit CheungStephen Kwok Wing Tsui
Feb 19, 2013·American Journal of Human Genetics·Audrey V GrantLaurent Abel
Mar 12, 2013·Pulmonary Medicine·Padmanesan NarasimhanDilip Mathai
Apr 27, 2013·Nature Reviews. Immunology·Nobuhiko KamadaGabriel Núñez
Jun 4, 2013·Nature Immunology·Ildiko Van RhijnD Branch Moody
Jun 6, 2013·Expert Review of Respiratory Medicine·Robert P DicksonGary B Huffnagle
Jun 12, 2013·Thorax·Chang-Hoon LeeJae-Joon Yim
Jul 23, 2013·Cell Host & Microbe·Elisa DeriuManuela Raffatellu
Dec 18, 2013·Proceedings of the National Academy of Sciences of the United States of America·Kei E FujimuraSusan V Lynch

❮ Previous
Next ❯

Citations

Jan 29, 2020·Annals of the New York Academy of Sciences·John Osei SekyerePetrus B Fourie
May 14, 2020·PLoS Neglected Tropical Diseases·Sivaranjani NamasivayamMamoudou Maiga
Aug 20, 2020·Applied Microbiology and Biotechnology·Aravind SundararamanPrakash M Halami
Jun 27, 2019·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Joshua H GordonJean Wactawski-Wende
Mar 7, 2020·Frontiers in Cellular and Infection Microbiology·Raphaël EnaudLaurence Delhaes
Feb 25, 2020·Indian Journal of Microbiology·Nirjara SinghviRup Lal
Jun 11, 2020·Seminars in Immunopathology·Renata RamalhoMarkus Maeurer
Oct 13, 2020·PloS One·Claudia SalaStewart T Cole
Feb 13, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Siu Wah Wong-DeyrupHong-Jie Zhang
Dec 16, 2020·Ageing Research Reviews·Vinciane Saint-CriqMuriel Thomas
Apr 1, 2021·Archives of Medical Research·Shilia Jacob KurianMahadev Rao
Apr 16, 2021·PLoS Pathogens·Giorgia MoriAntje Blumenthal
May 28, 2021·European Respiratory Review : an Official Journal of the European Respiratory Society·Christina S ThorntonDina A Fisher
Jul 28, 2019·Microbiology Spectrum·Gabriel T MashabelaDigby F Warner
May 25, 2021·Frontiers in Nutrition·Yue LiuChangxin Wu
Jul 16, 2021·PLoS Pathogens·Danielle Karo-AtarIrah L King
Dec 3, 2020·Journal of Agricultural and Food Chemistry·Zhen-Dong YaoGang Zhao
Nov 24, 2021·MBio·Diogo SilvérioMargarida Saraiva

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.